TherapeuticsMD, Inc. (TXMD) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

TherapeuticsMD, Inc. (TXMD) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

TXMD Cash Flow Statement

TherapeuticsMD, Inc. (TXMD) cash flow statement — 30-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	770K	936K	368K	1.05M	324K	686K	12K	-185K	894K	11K	-7.84M	-2.46M	-4.67M	-33.17M	59.77M	10.41M	115.81M	-29.53M	-39.56M	-38.22M
Operating CF Margin %	88.61%	129.28%	41.21%	133.42%	34.03%	174.55%	1.8%	-33.82%	382.05%	3.51%	-1561.95%	4632.08%	-1068.65%	-7974.76%	5188.54%	49.79%	405.48%	-152.72%	-211.79%	-150.45%
Operating CF Growth %	137.65%	36.44%	2966.67%	665.41%	-63.76%	6136.36%	100.15%	92.46%	119.14%	100.03%	-113.12%	-123.57%	-104.03%	-12.36%	251.1%	127.25%	536.48%	23.07%	-30.46%	-12.26%
Net Income	164K	103K	-612K	50K	545K	-636K	252K	-567K	-1.09M	-809K	-1.54M	-1.43M	-2.41M	-2.31M	-33.22M	-14.63M	-14.87M	-17.88M	-42.96M	-47.42M
Depreciation & Amortization	329K	325K	906K	96K	96K	95K	100K	96K	180K	133K	637K	130K	128K	27K	-1.99M	273K	282K	329K	1M	1.03M
Stock-Based Compensation	0	0	0	0	0	0	24K	0	96K	0	0	0	0	0	2.98M	0	0	0	5.35M	7.31M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	8K	-6K	-486K	295K	160K	252K	-903K	115K	936K	537K	-3.48M	4.41M	-857K	-23.99M	97M	-3.02M	138.75M	-9.6M	1.52M	2.44M
Working Capital Changes	269K	514K	560K	605K	-477K	975K	539K	171K	772K	150K	-3.46M	-5.56M	-1.53M	-6.9M	-5M	27.79M	-8.36M	-2.38M	-4.46M	-1.59M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	-19K	0	13.65M	-11.09M	489K	1.23M	-4.02M
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-551K	2.82M	-1.42M	-260K	-368K
Change in Payables	423K	-340K	114K	-87K	174K	-82K	0	91K	4K	112K	-669K	-812K	-818K	164K	4.97M	-430K	-358K	-502K	726K	5.03M
Cash from Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	81.16M	-126K	111K	-212K	-1.51M	-182K
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21K	7K	-76K	-212K	-1.51M	70K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	1561.95%	-	-	-	1.82%	0.03%	0.27%	1.1%	8.11%	0.28%
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	81.14M	-133K	187K	0	0	-252K
Cash from Financing	0	0	0	0	0	0	0	0	0	0	2M	-1.11M	1.15M	1.11M	-129.95M	1.74M	-120M	-5M	1.35M	31.82M
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-94.43M	0	-120M	-5M	0	0
Equity Issued (Net)	0	0	0	0	0	0	0	0	0	0	2M	-1K	1.15M	0	-33.23M	2.47M	0	0	1.23M	31.95M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	0	0	0	0	0	-1.11M	1K	1.11M	-2.29M	-729K	0	0	119K	-131K
Net Change in Cash	770K	936K	368K	1.05M	324K	686K	12K	-185K	894K	11K	-5.84M	-3.56M	-3.52M	-21.08M	10.99M	777K	7.17M	-34.74M	-39.72M	-6.58M
Free Cash Flow	770K	936K	368K	1.05M	324K	686K	12K	-185K	894K	11K	0	-2.46M	-4.67M	-33.17M	59.73M	10.41M	115.83M	-29.57M	-41.07M	-38.41M
FCF Margin %	88.61%	129.28%	41.21%	133.42%	34.03%	174.55%	1.8%	-33.82%	382.05%	3.51%	-	4632.08%	-1068.65%	-7974.76%	5185.33%	49.79%	405.55%	-152.94%	-219.9%	-151.17%
FCF Growth %	137.65%	36.44%	2966.67%	665.41%	-63.76%	6136.36%	-	92.46%	119.14%	100.03%	-100%	-123.57%	-104.03%	-12.2%	245.44%	127.12%	535.1%	23.09%	-33.28%	-11.93%
FCF per Share	0.07	0.08	0.03	0.09	0.03	0.06	0.00	-0.02	0.08	0.00	-	-0.23	-0.46	-3.40	6.38	1.12	12.79	-3.43	-4.81	-4.55
FCF Conversion (FCF/Net Income)	4.97x	9.85x	-0.59x	6.88x	0.59x	-1.05x	0.05x	0.30x	-0.82x	-0.01x	8.88x	0.73x	1.93x	9.21x	-1.80x	-0.36x	1.03x	0.41x	0.92x	0.81x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.17M	0	0	0	5.39M	5.39M
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0